AI-Driven Drug Discovery: Current Successes and Limitations
Drug discovery has always been a high-risk process. Identifying a promising biological target, finding a molecule that can influence it, optimizing that molecule for safety and pharmacokinetics, and then demonstrating clinical benefit can take many years. Most candidates fail somewhere along the way, making pharmaceutical R&D expensive and resource-intensive. AI-driven drug discovery is changing how…

